Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/59760
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

Checkpoint kinase 1 modulates sensitivity to cisplatin after spindle checkpoint activation in SW620 cells

AuthorsPeralta-Sastre, A.; Manguan-García, Cristina CSIC; Luis, Alberto de; Belda-Iniesta, Cristobal; Moreno, Sergio CSIC ORCID; Perona Abellón, Rosario CSIC ORCID; Sánchez-Pérez, Isabel
Issue Date2010
PublisherElsevier
CitationInternational Journal of Biochemistry and Cell Biology 42(2): 318-328 (2010)
AbstractAneuploidy is a common feature of tumours that arise by errors in chromosome segregation during mitosis. The aim of this study was to evaluate possible signaling pathways involved in sensitization to chemotherapy in cells with chromosomal instability. We designed a screen using the fission yeast Squizossaccharomyces pombe, to isolate strains showing a phenotype of chromosome mis-segregation and higher sensitivity to the antitumoral drug Bleomycin. We examined differences in gene expression using a comparative analysis of genome-wide expression of the wild type strain and one of the mutants. The results revealed a set of genes involved in cell cycle control, including Mad3/BubR1 and Chk1. We then studied the levels of these two proteins in colorectal cancer human cell lines with different genomic content. Among these, SW620 cells showed higher BubR1 and Chk1 mRNA levels than control cells under normal conditions. Since Chk1 is required for both S and G2/M checkpoints, and the microtubule-destabilizing agent, nocodazole induces mitotic arrest, we attempted to investigate the potential anticancer effects of nocodazole in combination with cisplatin. These studies showed that SW620 cells undergo synergistic cell death after spindle checkpoint activation followed by cisplatin treatment, suggesting a role of Chk1 in this checkpoint, very likely dependent on BubR1 protein. Importantly, Chk1-depleted SW620 cells lost this synergistic effect. In summary, we propose that Chk1 could be a biomarker predictive of the efficacy of chemotherapy across different types of tumors with aneuploidy. These findings may be potentially very useful for the stratification of patients for treatment.
URIhttp://hdl.handle.net/10261/59760
DOI10.1016/j.biocel.2009.11.011
Identifiersdoi: 10.1016/j.biocel.2009.11.011
issn: 1357-2725
Appears in Collections:(IBMCC) Artículos
(IIBM) Artículos

Files in This Item:
File Description SizeFormat
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work

SCOPUSTM   
Citations

5
checked on May 12, 2022

WEB OF SCIENCETM
Citations

5
checked on May 13, 2022

Page view(s)

352
checked on May 16, 2022

Download(s)

87
checked on May 16, 2022

Google ScholarTM

Check

Altmetric

Dimensions


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.